The Lancet Neurology

Multimedia | Podcasts | In conversation with | The Lancet Neurology

👂Podcast alert!! Listen to our our conversation with Professor Michael Rafii about Down syndrome-related Alzheimer's disease here: tinyurl.com/59nvbxam

#DownSyndrome #AlzheimersDisease #Neurology

A crisis of credibility: the global cost of US vaccine misinformation The global health community faces a deepening challenge—not only from infectious diseases but also from a pandemic of misinformation.1 The USA, long a cornerstone of global health leadership, has beco...

“The world cannot afford another crisis in which lives are lost not for lack of vaccines, but for lack of truth.”

A new Comment on the global cost of US vaccine misinformation: bit.ly/3Uu7b5o

Neurorehabilitation as a cornerstone of recovery An estimated 3·4 billion people worldwide live with a neurological disease or the consequences of acquired brain injuries, including stroke, traumatic brain injury, and spinal cord injury. Neurologica...

🧠 This month, we're diving into why neurorehabilitation must put patients first—discover why a patient-centred approach matters! Read our editorial: tinyurl.com/5n7atrd5

Plus: Our featured Insight explores how neurorehabilitation could lead the shift toward systems medicine: tinyurl.com/yjjhah4b

🧠Our September issue is live!

This month:
🔬Primary cilia in neurological disorders
🧬Down syndrome & Alzheimer's: biomarkers, clinical symptoms & pathology
💪Advances in management of idiopathic inflammatory myopathies

And much more about brain health, diagnostics treatment: tinyurl.com/yc365yh8

Will MR-guided focused ultrasound play an important role in the future treatment of patients with movement disorders and neurodegenerative diseases? According to the Personal View published in our latest issue, it is a therapeutic approach worth paying attention to! tinyurl.com/anezynz7

With the global burden of neurological disease and acquired brain injury rising, neurorehabilitation becomes ever more important. An article published in our last issue, tests the safety and and effectiveness of the Walk ‘n Watch exercise protocol for stroke rehabilitation: tinyurl.com/y4sjwbf7

Alt: Promotional card for the launch of the Lancet Series on Alzheimer's disease on 23rd September 2025. Background image depicts a hand holding a neuron and a brain with one half of it deteriorating. Copyright: Hopitaux Universitaires Geneve.

📣 Launch of the Lancet Series on Alzheimer’s disease.

On Sept 23, join the authors of the Series as they present the most clinically actionable, patient-relevant, updated, and trusted information on the disease available to date.

Register now ➡️ bit.ly/3UdB4qs

The relevance of primary cilia in neurological disorders Primary cilia are ubiquitous organelles, which play essential roles in sensing and transducing cellular signals and in mediating key developmental pathways. Pathogenic variants in genes encoding for c...

Or latest #OnlineFirst publication is a review on the relevance of primary cilia in neurological disorders. Have a read here: tinyurl.com/2pdzssdv

Have you checked out our latest podcast on fenebrutinib for relapsing multiple sclerosis yet?

Listen here: tinyurl.com/59nvbxam

Read the associated paper here: tinyurl.com/3r5dv99j

NEW ISSUE ALERT!!🗞️🧠 Featuring physiotherapy after stroke, updates to the ILAE seizure classification, focused ultrasound therapy for movement disorders, α-synuclein biomarker assays, fenebrutinib in multiple sclerosis and much more: tinyurl.com/muj5ycp3
#Neurology #Brain

Can we increase awareness of the burden of #MultipleSclerosis in #Africa? Read this correspondence article in our last issue: tinyurl.com/sd5p2rw7

Have you read the longitudinal cohort study on amyloid and tau brain deposition and cognitive decline in people with Down syndrome yet? It's featured #OpenAccess in #TheLancetNeurology: tinyurl.com/bdeeem25
#DownSyndrome

#Haemorrhage #Neurology #FunctionalRecovery

A pooled analysis of of the four INTERACT trials suggests intensive blood pressure-lowering initiated within several hours of intracerebral haemorrhage onset was safe and improved functional recovery, without a clear effect on haematoma growth. Check it out in our latest issue: tinyurl.com/mrnmv5f6

Are you ready for your research to spark global conversation? ✨ Begin your publication journey with us today and help to advance health and science worldwide.
hubs.li/Q03vpxN70

Congratulations to our authors and peer reviewers, whose expertise and hard work enable us to continuously publish some of the best science for better lives. This is as much your achievement!

We are the world-leading clinical neurology journal. While a partial measurement of our impact, we are pleased to share our Impact Factor of 45·5 and CiteScore of 62·6.
hubs.li/Q03vcpWK0

Our recent issue features a thought insightful comment on the diagnostic and clinical potential of the α-synuclein seed amplification assay. Check it out here: tinyurl.com/2aaky4bx
#Parkinsons

June issue is live!🙌

Read #AI model to detect #CognitiveImpairment in Japan, #ChildhoodAdversity and #perinatal mental health, #tick-borne diseases in China & more!

🖋️Editorial: Delayed #endometriosis diagnosis in #AsiaPacific

🎨Cover: Xiaolin Xu, a painting with real leaf
🔗 tinyurl.com/4m7445jb

#FriedreichsAtaxia is more than a rare neurological disease—it’s a multisystem disorder that affects the heart, metabolism, and muscles as well as the brain. This review spotlights new breakthroughs, including the 1st approved treatment, and highlights the need for more research tinyurl.com/zxpaef2b

Early blood-thinning treatment safe and effective for stroke patients Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is currently recommended in UK guidelines, finds a new study led by UCL researchers.

New UCL-led research published in @thelancet.com shows starting blood thinners within 4 days of a stroke is safe & cuts risk of another stroke by 30% for people with atrial fibrillation (an irregular heartbeat). @uclqsion.bsky.social @hakimdehbi.bsky.social @ucl-cctu.bsky.social

Research in context panel for Lancet paper "Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis". Copyright: 2025 The Author(s). Published by Elsevier Ltd. CC By 4.0.

The US Agency for International Development (#USAID) funding has had a crucial role in improving global health.

A new study estimates that USAID programs have saved nearly 92 million lives over past 20 years.

Explore the research ▶️ tinyurl.com/2w2nkvv3

Read the full article here: tinyurl.com/5a28yxv6

#EpilepsyAwareness #ReproductiveHealth #Neurology

Have you checked out our latest podcast episode? 🎙️
Sarah Passey talks with Dr. Marte-Helene Bjørk from Haukeland University Hospital (Norway) about reproductive risks in people with epilepsy—an important and often overlooked topic:
Apple: tinyurl.com/2kmzamhm
Spotify: tinyurl.com/4cyvecmw
#Epilepsy

Figure providing an overview of the diagnosis and management of cerebral palsy. Copyright: 2025 Elsevier Ltd. All rights are reserved.

Cerebral palsy is a lifelong physical disability affecting movement and posture.

🆕 A Seminar highlights the latest available evidence and recent progress in care to help clinicians address key questions.

Explore 👉 tinyurl.com/pvuz2zvy

Check out our July issue featuring blood pressure lowering after acute intracerebral haemorrhage, the potential of the α-synuclein seed amplification assay, cognitive decline in Down syndrome and more: tinyurl.com/3pvve45t

Geoff Manley on a new classification system for traumatic brain injury - The Lancet Neurology in conversation with Assistant Editor Sam Griffiths is joined by Professor Geoff Manley (UCSF, CA, USA) to discuss his new NIH-NINDS classification of acute TBI, the limitations of traditional classifications, how the new...

PODCAST: Sam Griffiths is joined by Geoff Manley to discuss the new NIH-NINDS classification of acute TBI and what it means for the future of TBI research and patient care. www.buzzsprout.com/1391383/epis...

NEW ISSUE: Read the latest content on ischaemic stroke and transient ischaemic attack, amyotrophic lateral sclerosis, traumatic brain injury, Alzheimer's disease, CSF transport, Parkinson's disease and more at: thelancet.com/journals/lan...

Text is on a purple background and says "Publish with us. Dedicated to bridging clinical evidence and practice to transform the lives of women". An illustration in pink depicts women in medicine.

We’re dedicated to publishing original research, evidence-based reviews, and insightful features on #womenshealth and #obgyn, throughout the entire life course—from adolescence to menopause and beyond.
Explore our aims and scope and submit your manuscript today! Find out more ➡️ bit.ly/3E6vIsq

Figure showing CAR T-cell therapy-associated neurotoxicities. Copyright: Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Neurological problems are a significant concern for patients receiving CAR T-cell therapy, yet there are no best practice guidelines.

In @thelancetoncol.bsky.social, a Review provides guidance on managing neurological issues associated with CAR T-cell therapy: tinyurl.com/3fxd5vtt